Advance Search

IDENTIFIKASI GENOTIP CTX-M PADA Escherichia coli PENGHASIL EXTENDED SPECTRUM BETA LACTAMASE (ESBL) YANG RESISTEN PADA CEPHALOSPORIN GENERASI III DI RSUP WAHIDIN SUDIROHUSODO MAKASSAR

DOI: https://doi.org/10.20956/mff.v23i1.6458
Article History

Submited : May 8, 2019
Published : May 9, 2019

Penelitian ini bertujuan untuk mengetahui untuk mendaptkan gambaran tentang prevalensi kejadian Escherichia coli penghasil ESBL yang resisten terhadap cephalosporin generasi III pada pasien RSUP Dr. Wahidin Sudirohusodo Makassar dan prevalensi genotif CTX-M Escherichia coli penghasil ESBL yang resisten terhadap cephalosporin generasi III pada pasien RSUP Dr. Wahidin Sudirohusodo Makassar. Penelitian dilaksanakan diruang perawatab rawat inap, ruang ICU, ruang HCU, ruang PICU, ruang IGD anak, Infection Center, laboratorium patologi klinik RSUP Dr. Wahidin Sudirohusodo dan laboratorium mikrobiologi klinik RSP Universitas Hasanuddin Makassar periode Juni 2018 – Agustus 2018. Penelitian ini menggunakan desain eksperimental laboratorium dengan teknik pengambilan sampel secara consecutive sampling. Bakteri Escherichia coli diisolasi dari 50 pasien. Pengujian dilakukan meliputi uji sensitivitas antibiotika dengan mengunakan metode difusi agar Kirby-bauer dan vitek 2 compact, uji deteksi ESBL dengan metode Double Disc Synergy Test (DDST), Phenotypic Confirmatory Test dan Uji genotip CTX-M Polymerase Chain Reaction (PCR). Hasil penelitian menunjukkan uji sensitivitas antibiotika pada 50 sampel klinik (Urin, Sputum, Darah, Feses, Pus dan Jaringan) yang diuji terhadap antibiotika golongan sefalosporin generasi III yang telah mengalami resistensi sebesar 40 isolat (80%) baik pada Ceftriaxone, Cefotaxime dan Ceftazidine. Pada uji fenotip dengan metode DDST dan Vitek 2 compact ditemukan 40 sampel (80%) positif ESBL pada Antibiotika Cefotaxime+As.Klavulanat (30 ųg/10 ųg ) maupun Ceftazidine+As.Klavulanat (30 ųg/10 ųg ). Pada uji genotip CTX-M di temukan 41 sampel (82%) memiliki gen CTX-M penghasil ESBL

References

  1. Carter GR, Wise DJ. 2004. Essential of Veterinary Bacteriology and Mycology. 6th Ed. Iowa : Blackwell Publishing.
  2. Branger Catherine et. Al., 2018, Extended-spectrum β-lactamase-encoding genes are spreading on a wide range of Escherichia coli plasmids existing prior to the use of third-generation cephalosporins, Microbial Genomics 2018;4
  3. Bradford,P.A.(2001).Extended-spectrum beta-lactamases in the 21stcentury: characterization, epidemiology, and detection of this important resistance threat. Clin.Microbiol.Rev. 14,933–951.doi:10.1128/CMR.14.4.933-951.2001
  4. Gutkind, G. O., Di Conza, J., Power, P., and Radice, M. (2013). beta-lactamase mediated resistance: a biochemical, epidemiological and genetic overview. Curr. Pharm. Des. 19, 164–208. doi: 10.2174/1381612811306020164
  5. Paterson, D.L., Bonomo, R.A. 2005. Extended-Spectrum Beta-Lactamases: A Clinical Update. Clin Microbiol Rev. 18(4):657-86.
  6. Al-Agamy MH, Shibl AM, Tawfik AF. Prevalence and molecular characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Ann Saudi Med.2009;29(4):253–7.
  7. Munier GK, Johnson CL, Snyder JW, Moland ES, Hanson ND, Thomson KS. 2010, Positive extended-spectrum-beta-lactamase (ESBL) screening results may be due to AmpC beta-lactamases more often than to ESBLs. J Clin Microbiol. 48(2)
  8. Bush K, 2010, Alarming beta lactamase-mediated resistance in multidrug resistant Enterobacteriaceae. Current Opinion in Microbiology (13). Elsevier; 558-564
  9. Bonnet R., 2004, Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother.;48(1):1–14.
  10. Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L., 2003, Prevalence and molecular epidemiology of CTX-M extendedspectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother; 47(12):3724–32
  11. Wang, P., Hu, F., Xiong, Z., Ye, X., Zhu, D., et al. 2011. Susceptibility of Extended Spectrum Beta Lactamase Producing Enterobacteriaceae According to the New CLSI Breakpoints. J Clin Microbiol. 49(9):3127-31
  12. Shaik, S., Fatima, J., Shakil, S., Rizvi, M.D., et al. 2015. Antibiotic Resistance and Extended Spectrum Beta-Lactamases: Types, Epidemiology and Treatment. Saudi Journal of Biological Sciences. 22, 90-101.
  13. Kuper, K.M., Boles, D.M., Mohr, J.F., Wanger, A., 2009. Antimicrobial susceptibility testing: primer for clinicians. Pharmacotherapy 29 (11), 1326–1343
  14. Pincus David H., 2006, Microbial Identification Using The Biomérieux Vitek® 2 System, Encyclopedia of Rapid Microbiological Methods, bioMérieux, Inc. Hazelwood, MO, USA
  15. Karowsky J A. et. al. 2010. Multidrug resistant urinary tract isolates of Escherichia coli : prevalence and patient demographics in the United states in 2009. Antimicrob Agents Chemother; 45(5) : 1402-06.
  16. Hanna E Sidjabat , David L Paterson,. 2015, Multidrug-resistant Escherichia coli in Asia: epidemiology and management, UQ Centre for Clinical Research The University of Queensland, ISSN 1478-7210 Queensland
  17. Smyth EG, O'Connell N .2004. Complicated urinary tract infection. Drugs & Therapy Perspectives; 11(1): 63-6.
  18. Prihatini, Aryati, Hetty., 2007, Identifikasi Cepat Mikroorganisme Menggunakan Alat Vitek-2 Compact, Indonesian Journal of Clinical Pathology and Medical Laboratory, Vol. 13, No. 3 : 29-132 Airlangga University Press,Surabaya
  19. Kementerian Kesehatan RI. 2012. Tentang Pedoman Umum Penggunaan Antibiotika. Depkes RI : Jakarta
  20. World Health Organization (WHO). 2014. Antimicrobial Resistance: Global Report on Surveillance 2014.
  21. Kuntaman Kuntaman, Sanarto Santoso, Hendro Wahjono, Ni Made Mertaniasih, Endang S. Lestari, Helmia Farida, Rebriarina Hapsari, Stefani Candra Firmanti, Noorhamdani AS, Dewi Santosaningsih, Priyo Budi Purwono, Deby Kusumaningrum, 2010, The sensitivity pattern of extended spectrum beta lactamase producing bacteria against six antibiotics that routinely used in clinical setting, Journal Indonesian Medical Association Volume: 61, Nomor: 12
  22. Severin Julie¨tte A., Ni Made Mertaniasih, Kuntaman Kuntaman, Endang S. Lestari, Marijam Purwanta, Nicole Lemmens-Den Toom, D. Offra Duerink, Usman Hadi, Alex van Belkum, Henri A. Verbrugh and Wil H. Goessens., 2010, Molecular characterization of extended-spectrum b-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy, England
  23. Centers for Disease Control and Prevention (CDC., 2013, U.S Department of Health and Human Services, Antibiotic Resistance Threats in The United States.
  24. Brown, L., Wolf, J.M., Prados-Rosales, R. and Casadevall, A., 2015. Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi. Nature Reviews Microbiology, 13(10), p.620.
  25. Rafael Cantón, Teresa M Coque., 2006, The CTX-M β-lactamase pandemic, Current Opinion in Microbiology Volume 9, Issue 5, Pages 466-475
  26. Edward R. Bevan, Annie M. Jones and Peter M. Hawkey., 2017, Global epidemiology of CTX-M Beta lactamases: temporal and geographical shifts in genotype, Journal of antimicrobial chemotherapy
  27. Ade Yulianto Prasetya., 2014, Pola Distribusi Gen SHV, TEM dan CTX-M pada Isolat Klinis Escherichia coli Penghasil Extended Spectrum beta lactamases (ESBLs) dari Urin Pasien di RSUD Dr. Soetomo Surabaya, Universitas Airlangga, Surabaya
  28. Miro E, del Cuerpo M, Navarro F, Sabate M, Mirelis B, Prats G. 1998. Emergence of Clinical Escherichia coli Isolates with Decreased Susceptibility to Ceftazidime and Synergic Effect with Co-Amoxiclav Due to SHV-1 Hyperproduction. J. Antimicrob. Chemother. 42:535–538.
  29. Rice LB, Carias LL, Hujer AM, Bonafede M, Hutton R, Hoyen C, Bonomo RA. 2000. High-level Expression of Chromosomally Encoded SHV-1 Beta-Lactamase and An Outer Membrane Protein Change Confer Resistance to Ceftazidime and Piperacillin Tazobactam in a Clinical Isolate of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44:362–367.
Pratama, A. S., Djide, M. N., & Massi, M. N. (2019). IDENTIFIKASI GENOTIP CTX-M PADA Escherichia coli PENGHASIL EXTENDED SPECTRUM BETA LACTAMASE (ESBL) YANG RESISTEN PADA CEPHALOSPORIN GENERASI III DI RSUP WAHIDIN SUDIROHUSODO MAKASSAR. Majalah Farmasi Dan Farmakologi, 23(1), 5-9. https://doi.org/10.20956/mff.v23i1.6458

Downloads

Download data is not yet available.
Fulltext
PDF